All cognitive systems but speed and visuospatial functions reduce the effect of CSF pathology on other systems

Current Alzheimer Research

Volumn 9, Issue 9, 2012, Pages 1043-1049

  Rolstad, Sindre ^a   Berg, Anne I ^b   Zetterberg, Henrik ^a   Johansson, Boo ^b   Wallin, Anders ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cerebrospinal fluid; Cognition; Cognitive reserve; Dementia; Mild cognitive impairment

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN;

ADULT; ARTICLE; CEREBROSPINAL FLUID; COGNITIVE RESERVE; CONTROLLED STUDY; DEPTH PERCEPTION; EXECUTIVE FUNCTION; FEMALE; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SEMANTIC MEMORY; VERBAL COMMUNICATION; VERBAL MEMORY; WORKING MEMORY;

AGED; AMYLOID BETA-PEPTIDES; COGNITIVE RESERVE; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; TAU PROTEINS;

EID: 84870186661     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720512803568966     Document Type: Article

References (59)

1. Satz P. Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory. Neuropsychology 7(3): 273-295 (1993).
2. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 8(3): 448-460 (2002).
3. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, et al. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120(5): 701-713 (2005).
4. van Praag H, Shubert T, Zhao C, Gage FH. Exercise enhances learning and hippocampal neurogenesis in aged mice. J Neurosci 25(38): 8680-8685 (2005).
5. Brickman AM, Siedlecki KL, Muraskin J, Manly JJ, Luchsinger JA, Yeung LK, et al. White matter hyperintensities and cognition: Testing the reserve hypothesis. Neurobiol Aging 32(9): 1588-1598 (2011).
6. Mortimer JA, Snowdon DA, Markesbery WR. Head circumference, education and risk of dementia: findings from the Nun Study. J Clin Exp Neuropsychol 25(5): 671-679 (2003).
7. Valenzuela MJ, Sachdev P. Brain reserve and dementia: a systematic review. Psychol Med 36(4): 441-454 (2006).
8. Gale CR, Walton S, Martyn CN. Foetal and postnatal head growth and risk of cognitive decline in old age. Brain 126(Pt 10): 2273-228 (2003).
9. Borenstein Graves A, Mortimer JA, Bowen JD, McCormick WC, McCurry SM, Schellenberg GD, et al. Head circumference and incident Alzheimer's disease: modification by apolipoprotein E. Neurology 57(8): 1453-1460 (2001).
10. Schofield PW, Mosesson RE, Stern Y, Mayeux R. The age at onset of Alzheimer's disease and an intracranial area measurement. A relationship. Arch Neurol 52(1): 95-98 (1995).
11. MacLullich AM, Ferguson KJ, Deary IJ, Seckl JR, Starr JM, Wardlaw JM. Intracranial capacity and brain volumes are associated with cognition in healthy elderly men. Neurology 59(2):169-174 (2002).
12. Mori E, Hirono N, Yamashita H, Imamura T, Ikejiri Y, Ikeda M, et al. Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease. Am J Psychiatry 154(1): 18-24 (1997).
13. Kemppainen NM, Aalto S, Karrasch M, Nagren K, Savisto N, Oikonen V, et al. Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Ann Neurol 63(1): 112-118 (2008).
14. Alexander GE, Furey ML, Grady CL, Pietrini P, Brady DR, Mentis MJ, et al. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis. Am J Psychiatry 154(2): 165-172 (1997).
15. Scarmeas N, Zarahn E, Anderson KE, Habeck CG, Hilton J, Flynn J, et al. Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol 60(3): 359-365 (2003).
16. Siedlecki KL, Stern Y, Reuben A, Sacco RL, Elkind MS, Wright CB. Construct validity of cognitive reserve in a multiethnic cohort: The Northern Manhattan Study. J Int Neuropsychol Soc 15(4): 558-569 (2009).
17. Boyle PA, Wilson RS, Schneider JA, Bienias JL, Bennett DA. Processing resources reduce the effect of Alzheimer pathology on other cognitive systems. Neurology 701(7): 1534-1542 (2008).
18. Blennow K. CSF biomarkers for mild cognitive impairment. J Intern Med 256(3): 224-234 (2004).
19. Blennow K. Cerebrospinal fluid protein biomarkers for Alzheimer's disease. Neurology 1(2): 213-225 (2004).
20. Rolstad S, A. Nordlund, Eckerström, Gustavsson, MH, Zetterberg, H. & Wallin, A. Cognitive Reserve in Relation to Abeta42 in Patients Converting from MCI to Dementia - A Follow-Up Report. Dement Geriatr Cogn Disord 28: 110-115 (2009).
21. Rolstad S, Nordlund A, Eckerstrom C, Gustavsson MH, Blennow K, Olesen PJ, et al. High education may offer protection against tauopathy in patients with mild cognitive impairment. J Alzheimers Dis 21(1): 221-228 (2010).
22. Rolstad S, Nordlund A, Eckerstrom C, Gustavsson MH, Zetterberg H, Wallin A. Biomarkers in relation to cognitive reserve in patients with mild cognitive impairment--proof of concept. Dement Geriatr Cogn Disord 27(2): 194-200 (2009).
23. Nordlund A, Rolstad S, Hellstrom P, Sjogren M, Hansen S, Wallin A. The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition. J Neurol Neurosurg Psychiatry 76(11): 1485-1490 (2005).
24. Reisberg B, Ferris SH, de Leon MJ, Crook T. Global Deterioration Scale (GDS). Psychopharmacol Bull 24(4): 661-663 (1988).
25. Wallin A, Edman A, Blennow K, Gottfries CG, Karlsson I, Regland B, et al. Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia. J Geriatr Psychiatry Neurol 9(4): 185-199 (1996).
26. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3): 189-198 (1975).
27. Royall DR, Mahurin RK, Gray KF. Bedside assessment of executive cognitive impairment: the executive interview. J Am Geriatr Soc 40(12): 1221-1226 (1992).
28. Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 9(1): 173-176; discussion 7-8 (1997).
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7): 939-944 (1984).
30. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 59: 23-30 (2000).
31. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43(2): 250-260 (1993).
32. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65(12): 1863-1872 (2005).
33. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51(6): 1546-1554 (1998).
34. Diagnostic and statistical manual of mental disorders. 4th ed. Arlington, VA: American Psychiatric Publishing, Inc.; 1994.
35. Zetterberg H, Pedersen M, Lind K, Svensson M, Rolstad S, Eckerstrom C, et al. Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years. J Alzheimers Dis 12(3): 255-260 (2007).
36. Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 26(3): 231-245 (2007).
37. Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, et al. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol 56(6): 673-680 (1999).
38. Rolstad S, Berg AI, Bjerke M, Blennow K, Johansson B, Zetterberg H, et al. Amyloid-beta42 is Associated with Cognitive Impairment in Healthy Elderly and Subjective Cognitive Impairment. J Alzheimers Dis 26(1): 135-142 (2011).
39. Simes RJ. An improved Bonferroni procedure for multiple tests of significance. Biometrika 1986(73): 751-754.
40. Glantz SA, Slinker BK. Primer of Applied Regression and Analysis of Variance. New York: McGraw-Hill; 1990.
41. Giannakopoulos P, Herrmann FR, Bussiere T, Bouras C, Kovari E, Perl DP, et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 60(9): 1495-1500 (2003).
42. Samgard K, Zetterberg H, Blennow K, Hansson O, Minthon L, Londos E. Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity. Int J Geriatr Psychiatry 25(4): 403-410 (2010).
43. Engelborghs S, Sleegers K, Cras P, Brouwers N, Serneels S, De Leenheir E, et al. No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease. Brain 130(Pt 9): 2320-2326 (2007).
44. Strozyk D, Blennow K, White LR, Launer LJ. CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 60(4): 652-656 (2003).
45. Tapiola T, Overmyer M, Lehtovirta M, Helisalmi S, Ramberg J, Alafuzoff I, et al. The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease. Neuroreport 8(18): 3961-3963 (1997).
46. Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12(10): 383-388 (1991).
47. Salthouse TA. The processing-speed theory of adult age differences in cognition. Psychol Rev 103(3): 403-428 (1996).
48. Salthouse TA, Atkinson TM, Berish DE. Executive functioning as a potential mediator of age-related cognitive decline in normal adults. J Exp Psychol Gen 132(4): 566-594 (2003).
49. Stern Y, Zarahn E, Habeck C, Holtzer R, Rakitin BC, Kumar A, et al. A common neural network for cognitive reserve in verbal and object working memory in young but not old. Cereb Cortex 18(4):959-967 (2008).
50. Park DC, Reuter-Lorenz P. The adaptive brain: aging and neurocognitive scaffolding. Annu Rev Psychol 60: 173-196 (2009).
51. Fletcher PC, Henson RN. Frontal lobes and human memory: insights from functional neuroimaging. Brain 124(Pt 5): 849-881 (2001).
52. Wager TD, Smith EE. Neuroimaging studies of working memory: a meta-analysis. Cogn Affect Behav Neurosci 3(4): 255-274 (2003).
53. Binder JR, Frost JA, Hammeke TA, Cox RW, Rao SM, Prieto T. Human brain language areas identified by functional magnetic resonance imaging. J Neurosci 17(1): 353-62 (1997).
54. Friederici AD, Opitz B, von Cramon DY. Segregating semantic and syntactic aspects of processing in the human brain: an fMRI investigation of different word types. Cereb Cortex 10(7): 698-705 (2000).
55. Bartres-Faz D, Sole-Padulles C, Junque C, Rami L, Bosch B, Bargallo N, et al. Interactions of cognitive reserve with regional brain anatomy and brain function during a working memory task in healthy elders. Biol Psychol 80(2): 256-259 (2009).
56. Sole-Padulles C, Bartres-Faz D, Junque C, Vendrell P, Rami L, Clemente IC, et al. Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 30(7): 1114-1124 (2009).
57. Nordlund A, Rolstad S, Klang O, Lind K, Pedersen M, Blennow K, et al. Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI. J Int Neuropsychol Soc 14(4): 582-590 (2008).
58. van der Vlies AE, Verwey NA, Bouwman FH, Blankenstein MA, Klein M, Scheltens P, et al. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease. Neurology 72(12):1056-1061 (2009).
59. Rolstad S, Nordlund A, Eckerström C, Gustavsson M, Zetterberg, H. & Wallin, A. Biomarkers in relation to cognitive reserve in patients with Mild Cognitive Impairment - proof of concept. Dement Geriatr Cogn Disord 27: 194-200 (2009).